Zantac Lawsuit Eligibility: Cancers, Proof of Use and Records

If you or a loved one took Zantac and later received a cancer diagnosis, you may be wondering about Zantac lawsuit eligibility and whether your story fits what these cases have alleged. This guide walks through the basics in plain language: which cancers have been named in Zantac litigation, why use history and proof of use matter, what the FDA did in 2020, which records are worth gathering, and how filing deadlines generally work. It also explains, honestly, where the litigation stands as of October 2026, because the legal picture has changed a lot.

Direct2Attorney is not a law firm and does not give legal advice. We connect people with participating law firms, and a participating law firm decides whether to take any case. Nothing here is a promise of compensation.

What Is Behind the Zantac Cancer Lawsuits?

Zantac is the best-known brand name for ranitidine, a heartburn and acid-reflux medicine that was sold for decades, both over the counter and by prescription. In 2019, testing raised concerns that ranitidine products could contain N-nitrosodimethylamine, usually shortened to NDMA. The FDA describes NDMA as a probable human carcinogen, meaning a substance that could cause cancer at sufficient exposure levels.

On April 1, 2020, the FDA asked manufacturers to immediately withdraw all prescription and over-the-counter ranitidine products from the U.S. market. According to the agency, its testing found that the NDMA impurity in some ranitidine products increased over time and when products were stored at higher than room temperature. You can read the agency’s announcement on the FDA website. The FDA advised consumers to stop taking over-the-counter ranitidine and to talk with a doctor about alternatives.

Thousands of people later filed lawsuits alleging that long-term Zantac use contributed to their cancer and that manufacturers should have warned about the NDMA risk. The companies have denied these claims, and courts have not found that Zantac causes cancer. That background shapes every question about Zantac lawsuit eligibility today.

Zantac Lawsuit Eligibility: The Basic Factors

There is no single official checklist for Zantac lawsuit eligibility. Each participating law firm uses its own criteria, and those criteria may change as courts rule. In general, though, firms reviewing a possible Zantac cancer lawsuit have tended to look at a few core questions:

• Use: Did the person take brand-name Zantac or generic ranitidine, and can that use be shown with records?
• Duration and frequency: How long and how often was it used? Many claims have focused on regular use over an extended period.
• Diagnosis: Was there a diagnosed cancer, confirmed by medical records, of a type that has been alleged in the litigation?
• Timing: Did the use come before the diagnosis, and is the claim still within the deadlines that apply in the relevant state?
• Prior claims: Has the person already filed a claim, joined a settlement, or had a case dismissed?

Meeting these general factors does not mean a case will be accepted. Zantac lawsuit eligibility ultimately depends on a law firm’s independent review of the facts, the law in your state, and the current status of the courts handling these cases.

Which Cancers Have Been Alleged in Zantac Lawsuits?

Early in the litigation, plaintiffs named more than ten types of cancer. In the federal multidistrict litigation (MDL No. 2924, in the Southern District of Florida), the claims were later narrowed to five so-called designated cancers:

• Bladder cancer
• Esophageal cancer
• Stomach (gastric) cancer
• Liver cancer
• Pancreatic cancer

Some lawsuits and law firm intake programs have also mentioned other cancers, such as colorectal, kidney, prostate, breast, or lung cancer. Allegations are not the same as proof, however. Courts have closely examined the science linking ranitidine to each cancer type, and a cancer appearing on a list does not mean it would support a Zantac cancer lawsuit today.

If your diagnosis is not on the list above, it can still be worth asking a participating law firm whether it is reviewing that cancer type. Questions about Zantac lawsuit eligibility for a particular diagnosis are exactly what a case review is meant to answer.

Proof of Use: Why Your Zantac History Matters

For any Zantac cancer lawsuit, one of the first things a law firm is likely to ask is how you can show that you took the drug. Because ranitidine was sold over the counter for many years, plenty of people bought it at the pharmacy shelf without a prescription, which can make proof of use harder.

Prescription Use

If a doctor prescribed ranitidine, pharmacy records and medical charts may show the drug name, dose, refill dates, and prescribing physician. These records often carry the most weight because they are created at the time of use. Many pharmacies can print a medication history on request.

Over-the-Counter Use

Proof of over-the-counter use can come from other places. Medical records sometimes list Zantac as a current medication even when it was bought at a store. Store loyalty programs, online order histories, credit card statements, and receipts may also help. Statements from family members or caregivers who remember the medicine in the home may add context, though they are usually weaker than documents.

Do not worry if your records are incomplete. Gaps are common, and a participating law firm can review what you have. Being honest about what you remember, and what you cannot, helps the firm assess Zantac lawsuit eligibility accurately.

What Records Should You Gather?

Getting organized before a case review can save time and help a law firm understand your situation. Helpful items often include:

• Pharmacy printouts or prescription records showing ranitidine or Zantac
• Medical records listing Zantac in your medication history
• Pathology reports and records confirming the cancer diagnosis and the date it was made
• Treatment records, such as surgery, chemotherapy, or radiation summaries
• Receipts, loyalty card histories, or online order records for over-the-counter purchases
• A simple written timeline: when you started and stopped Zantac, how often you took it, and when symptoms and diagnosis occurred
• Any letters or paperwork about a prior claim, settlement, or lawsuit
• For a family member who has passed away: the death certificate and any estate documents

You do not need every item on this list to ask about Zantac lawsuit eligibility. Bring what you have; a firm can explain what else might matter.

Where Zantac Litigation Stands as of October 2026

Anyone thinking about a Zantac cancer lawsuit should understand that recent court rulings have made these claims much more difficult. Here is a summary of the major developments, based on court reports and company filings we reviewed in October 2026.

Federal MDL and the Eleventh Circuit Appeal

In December 2022, Judge Robin Rosenberg, who oversaw the federal Zantac MDL, excluded the plaintiffs’ general causation experts and dismissed the federal claims involving the five designated cancers. Plaintiffs appealed to the U.S. Court of Appeals for the Eleventh Circuit, which heard oral argument on October 10, 2025. In a mid-2026 financial report, Sanofi stated that a decision was expected in the second half of 2026. Based on the sources we reviewed, the court had not issued a ruling as of early October 2026.

Delaware: Supreme Court Ruling and Dismissal

Delaware state court became the largest venue for Zantac claims. In 2024, a Delaware Superior Court judge allowed the plaintiffs’ expert testimony to go forward. On July 10, 2025, the Delaware Supreme Court reversed that decision, holding that the trial court had applied the wrong standard and that experts needed to reliably connect NDMA exposure to ranitidine use itself, not just to NDMA in general.

On remand, Judge Francis J. Jones granted summary judgment in April 2026, dismissing the Delaware Zantac cases filed on or before December 1, 2025, because plaintiffs could not prove general causation without their excluded experts. Reports describe tens of thousands of cases affected. According to Sanofi’s half-year 2026 report, plaintiffs have appealed to the Delaware Supreme Court, and Sanofi did not expect a decision before the fourth quarter of 2027.

Other State Courts

Reports on the Delaware ruling noted that state court judges in California and Illinois had allowed similar cancer evidence to proceed to trial. Results there have been mixed, and outcomes in one state do not control another.

Settlements

Several manufacturers have settled large groups of claims without admitting liability. In October 2024, GSK announced agreements to resolve about 80,000 state court cases, roughly 93% of its state court docket, for up to $2.2 billion. Pfizer agreed in May 2024 to settle more than 10,000 cases for an undisclosed amount, and Sanofi reportedly resolved about 4,000 claims for $100 million. For more on how settlements have unfolded, see our Zantac settlement update.

These settlements covered specific groups of existing claims. They do not mean that a new claim today would be paid, or paid in any particular amount. For a closer look at how survivors have been affected by these rulings, read where Zantac cancer survivors stand in 2026.

How Zantac Lawsuit Deadlines Generally Work

Every state has a statute of limitations, a deadline for filing a personal injury or product liability lawsuit. These deadlines vary by state and often fall in the range of a few years, though some are shorter or longer. Missing the deadline can bar a claim entirely, which makes timing a key part of Zantac lawsuit eligibility.

When the clock starts can also vary. Many states use a discovery rule, meaning the deadline may begin when a person knew, or reasonably should have known, about the injury and its possible cause. Some people argue that the 2019 and 2020 public news about NDMA in ranitidine started the clock, which could matter in a Zantac cancer lawsuit filed years later. Wrongful death claims usually have separate deadlines tied to the date of death.

Some states also have a statute of repose, an outer time limit that can apply regardless of when an injury was discovered. Because these rules are complex and fact-specific, only a licensed attorney in the right state can tell you which deadline applies to you. If you are unsure, it is generally better to ask sooner rather than later.

Can Family Members File on Behalf of a Loved One?

In many states, a spouse, child, or estate representative may be able to bring a wrongful death or survival claim if a person who used Zantac has died from cancer. Who may file, and when, depends on state law. The same questions about Zantac lawsuit eligibility apply: proof of use, a documented diagnosis, and timing. A participating law firm can explain how this works where you live.

What to Expect From a Free Case Review

If you want help understanding your options, you can learn more on our Zantac lawsuit page. The free case review is a short, confidential questionnaire about your Zantac use, your diagnosis, and key dates. With your permission, your information is shared with a participating law firm, and that firm decides whether to take the case.

Direct2Attorney does not evaluate claims or give legal advice, and there is no guarantee that a firm will accept a case or that any compensation will be recovered. Given recent rulings, some firms may not be accepting new Zantac claims, or may only accept certain types. A review simply helps you get an informed answer about Zantac lawsuit eligibility from a law firm.

Frequently Asked Questions

Who may be eligible for a Zantac cancer lawsuit?

Generally, law firms have looked at people who used Zantac or generic ranitidine regularly and were later diagnosed with a cancer alleged in the litigation, such as bladder, esophageal, stomach, liver, or pancreatic cancer. Zantac lawsuit eligibility also depends on state deadlines and on current court rulings, so a participating law firm must review each situation.

Is Zantac still sold in the United States?

Ranitidine was withdrawn from the U.S. market after the FDA’s April 2020 request. Products sold today under the Zantac 360 name contain a different active ingredient, famotidine, which is not part of the ranitidine NDMA claims.

What if I bought Zantac over the counter and have no receipts?

Many people are in this situation. Medical records that list Zantac, pharmacy histories, store loyalty data, and a detailed personal timeline may help. A participating law firm can review whatever evidence you have.

Are Zantac lawsuits still being filed in 2026?

As of October 2026, the federal appeal remains pending and the Delaware dismissal is on appeal, which makes new claims difficult. Some firms may still review certain cases, particularly in other state courts. Whether a new Zantac cancer lawsuit is possible depends on the facts and the law that applies.

How much is a Zantac lawsuit worth?

No one can predict the value of an individual claim. Past settlements covered specific groups of existing cases, and they do not set a value for future claims. Any case may result in no recovery.

Does Direct2Attorney decide if I qualify?

No. Direct2Attorney is not a law firm. We share the information from your confidential questionnaire with a participating law firm, and that firm decides whether to take the case.

Think you may qualify? See if you qualify for a free, confidential Zantac case review →

This article is general information, not legal or medical advice. Direct2Attorney is not a law firm and does not provide legal advice.